keyword
https://read.qxmd.com/read/38680985/systematic-review-autism-spectrum-disorder-and-the-gut-microbiota
#21
JOURNAL ARTICLE
Jenni Korteniemi, Linnea Karlsson, Anna Aatsinki
OBJECTIVE: Autism spectrum disorders (ASD) are a varying group of disorders characterized by deficiency in social interaction and restrictive patterns of behavior and interests. While there are several studies focusing on the neuro-psychiatric pathogenesis of ASD, its etiology remains unclear. The role of gut-brain-axis in ASD has been studied increasingly and a correlation between symptoms and the composition of gut microbiota has been documented in various works. Despite this, the significance of individual microbes and their function is still widely unknown...
April 2024: Focus: Journal of Life Long Learning in Psychiatry
https://read.qxmd.com/read/38680110/epidemiology-of-disorders-of-the-gut-brain-interaction-an-appraisal-of-the-rome-iv-criteria-and-beyond
#22
REVIEW
Gautam Ray, Uday Chand Ghoshal
Disorders of the gut-brain interaction (DGBIs) are presently classified into mutually exclusive anatomical area-related symptom-based categories according to the Rome IV criteria. The pathophysiology of visceral nociception, which contributes to the wide range of symptoms of DGBIs, involves complex psychobiological processes arising from the bidirectional interactions of multiple systems at the gut and brain levels, which affect symptom expression and illness behaviors. The attitude toward an illness and expression of pain and bowel habit vary across cultures with variable interpretation based on sociocultural beliefs, which may not tally with the medical definitions...
April 29, 2024: Gut and Liver
https://read.qxmd.com/read/38679241/antihypertensive-treatment-during-pregnancy-induces-long-term-changes-in-gut-microbiota-and-the-behaviors-of-the-attention-deficit-hyperactivity-disorder-offspring
#23
JOURNAL ARTICLE
Hong-Bao Li, Meng-Lu Xu, Wen-Jie Xia, Yuan-Yuan Dong, Bo Peng, Qing Su, Xiao-Min Wang, Jia-Yue Yu, Ya-Nan Gao, Jun-Zhe Wu, Meng-Yue Xu, Jin-Bao Yang, Zhi-Ming Dai, Lei Chen, Ying Li, Juan Bai
The pathogenesis of attention-deficit/hyperactivity disorder (ADHD) has not been fully elucidated. Gestational hypertension could double the probability of ADHD in the offspring, while the initial bacterial communication between the mother and offspring has been associated with psychiatric disorders. Thus, we hypothesize that antihypertensive treatment during pregnancy may abate the impairments in neurodevelopment of the offspring. To test this hypothesis, we chose Captopril and Labetalol, to apply to pregnant spontaneously hypertensive rat (SHR) dams and examined the outcomes in the male offspring...
April 26, 2024: Toxicology and Applied Pharmacology
https://read.qxmd.com/read/38679102/chronic-sub-lethal-exposure-to-clothianidin-triggers-organismal-and-sub-organismal-level-health-hazards-in-a-non-target-organism-drosophila-melanogaster
#24
JOURNAL ARTICLE
Sayantani Nanda, Abhratanu Ganguly, Moutushi Mandi, Kanchana Das, Siddhartha Ghanty, Gopal Biswas, Prem Rajak
Neonicotinoids are extensively used systemic pesticides across the globe. These chemicals have gathered significant attention for their potential adverse impacts on non-target organisms. Clothianidin is a novel neonicotinoid pesticide, widely used to control sucking and chewing types of pests. In nature, various non-target organisms can be exposed to this chemical. Nonetheless, extensive investigations demonstrating the sub-lethal impacts of clothianidin on non-targets are limited. Hence, the present study aimed to unravel the chronic sub-lethal impacts (LC50 0...
April 26, 2024: Science of the Total Environment
https://read.qxmd.com/read/38679006/gut-microbiota-moderates-multimodal-brain-structure-function-integration-and-behavioral-cognition-in-growth-hormone-deficient-children
#25
JOURNAL ARTICLE
Keren Wang, Yuchuan Fu, Lan Li, Lingfeng Zhang, Mei Huang, Weihao Yan, Xiaoou Shan, Zhihan Yan, Yi Lu
Background Previous brain studies of growth hormone deficiency (GHD) often used single-mode neuroimaging, missing the complexity captured by multimodal data. Growth hormone affects gut microbiota and metabolism in GHD. However, from a gut-brain axis perspective, the relationship between abnormal GHD brain development and microbiota alterations remains unclear. The ultimate goal is to uncover the manifestations underlying gut-brain axis (GBA) abnormalities in GHD and idiopathic short stature (ISS). Methods Participants included 23 GHD and 25 ISS children...
April 27, 2024: Neuroendocrinology
https://read.qxmd.com/read/38678955/berberine-alleviates-alzheimer-s-disease-by-regulating-the-gut-microenvironment-restoring-the-gut-barrier-and-brain-gut-axis-balance
#26
JOURNAL ARTICLE
Chunbin Sun, Shanshan Dong, Weiwei Chen, Jin Li, Enli Luo, Jiacui Ji
BACKGROUND: Alzheimer's disease (AD) is the most common neurodegenerative disease. Intestinal flora and its metabolism play a significant role in ameliorating central nervous system disorders, including AD, through bidirectional interactions between the gut-brain axis. A naturally occurring alkaloid compound called berberine (BBR) has neuroprotective properties and prevents Aβ-induced microglial activation. Additionally, BBR can suppress the synthesis of Aβ and decrease BACE1 expression...
April 21, 2024: Phytomedicine
https://read.qxmd.com/read/38678292/utilization-of-fluid-based-biomarkers-as-endpoints-in-disease-modifying-clinical-trials-for-alzheimer-s-disease-a-systematic-review
#27
JOURNAL ARTICLE
Marlies Oosthoek, Lisa Vermunt, Arno de Wilde, Bram Bongers, Daniel Antwi-Berko, Philip Scheltens, Pieter van Bokhoven, Everard G B Vijverberg, Charlotte E Teunissen
BACKGROUND: Clinical trials in Alzheimer's disease (AD) had high failure rates for several reasons, including the lack of biological endpoints. Fluid-based biomarkers may present a solution to measure biologically relevant endpoints. It is currently unclear to what extent fluid-based biomarkers are applied to support drug development. METHODS: We systematically reviewed 272 trials (clinicaltrials.gov) with disease-modifying therapies starting between 01-01-2017 and 01-01-2024 and identified which CSF and/or blood-based biomarker endpoints were used per purpose and trial type...
April 27, 2024: Alzheimer's Research & Therapy
https://read.qxmd.com/read/38678197/connection-of-pre-competition-anxiety-with-gut-microbiota-and-metabolites-in-wrestlers-with-varying-sports-performances-based-on-brain-gut-axis-theory
#28
JOURNAL ARTICLE
Pengyu Fu, Cuiping Wang, Shuai Zheng, Lei Qiao, Weiyang Gao, Lijing Gong
OBJECTIVE: The purpose of this study is to investigate the connection of pre-competition anxiety with gut microbiota and metabolites in wrestlers with different sports performances. METHODS: One week prior to a national competition, 12 wrestlers completed anxiety questionnaires. Faecal and urine samples were collected for the analysis of gut microbiota and metabolites through the high-throughput sequencing of the 16 S rRNA gene in conjunction with untargeted metabolomics technology...
April 27, 2024: BMC Microbiology
https://read.qxmd.com/read/38677442/development-of-a-synthetic-relaxin-3-insl5-chimeric-peptide-ligand-for-nanobit-complementation-binding-assays
#29
JOURNAL ARTICLE
Hongkang Wu, Bradley L Hoare, Thomas N G Handley, Mohammed Akhter Hossain, Ross A D Bathgate
INSL5 and relaxin-3 are relaxin family peptides with important roles in gut and brain function, respectively. They mediate their actions through the class A GPCRs RXFP4 and RXFP3. RXFP4 has been proposed to be a therapeutic target for colon motility disorders whereas RXFP3 targeting could be effective for neurological conditions such as anxiety. Validation of these targets has been limited by the lack of specific ligands and the availability of robust ligand-binding assays for their development. In this study, we have utilized NanoBiT complementation to develop a SmBiT-conjugated tracer for use with LgBiT-fused RXFP3 and RXFP4...
April 25, 2024: Biochemical Pharmacology
https://read.qxmd.com/read/38676489/neuroprotective-role-of-phytoconstituents-based-nanoemulsion-for-the-treatment-of-alzheimer-s-disease
#30
JOURNAL ARTICLE
Sukriti Vishwas, Bushra Bashir, Devendra Birla, Nikhil Khandale, Motamarri Venkata Naga Lalitha Chaitanya, Dinesh Kumar Chellappan, Gaurav Gupta, Poonam Negi, Kamal Dua, Sachin Kumar Singh
Alzheimer's disease (AD) is the most prevalent form of neurodegenerative disorder (ND), affecting more than 44 million individuals globally as of 2023. It is characterized by cognitive dysfunction and an inability to perform daily activities. The progression of AD is associated with the accumulation of amyloid beta (Aβ), the formation of neurofibrillary tangles (NFT), increased oxidative stress, neuroinflammation, mitochondrial dysfunction, and endoplasmic reticulum stress. Presently, various phytomedicines and their bioactive compounds have been identified for their neuroprotective effects in reducing oxidative stress, alleviating neuroinflammation, and mitigating the accumulation of Aβ and acetylcholinesterase enzymes in the hippocampus and cerebral cortex regions of the brain...
April 25, 2024: Current Topics in Medicinal Chemistry
https://read.qxmd.com/read/38675435/improved-chemical-and-radiochemical-synthesis-of-neuropeptide-y-y-2-receptor-antagonist-n-methyl-jnj-31020028-and-preclinical-positron-emission-tomography-studies
#31
JOURNAL ARTICLE
Inês C F Fonseca, Mariana Lapo Pais, Fábio M S Rodrigues, José Sereno, Miguel Castelo-Branco, Cláudia Cavadas, Mariette M Pereira, Antero J Abrunhosa
Neuropeptide Y (NPY) is one of the most abundant peptides in the central nervous system of mammals and is involved in several physiological processes through NPY Y1 , Y2 , Y4 and Y5 receptors. Of those, the Y2 receptor has particular relevance for its autoreceptor role in inhibiting the release of NPY and other neurotransmitters and for its involvement in relevant mechanisms such as feeding behaviour, cognitive processes, emotion regulation, circadian rhythms and disorders such as epilepsy and cancer. PET imaging of the Y2 receptor can provide a valuable platform to understand this receptor's functional role and evaluate its potential as a therapeutic target...
April 8, 2024: Pharmaceuticals
https://read.qxmd.com/read/38674579/psychobiotics-and-the-microbiota-gut-brain-axis-where-do-we-go-from-here
#32
REVIEW
Sylvie Binda, Annie Tremblay, Umar Haris Iqbal, Ola Kassem, Mélanie Le Barz, Vincent Thomas, Stéphane Bronner, Tara Perrot, Nafissa Ismail, J Alex Parker
The bidirectional relationship between the gut microbiota and the nervous system is known as the microbiota-gut-brain axis (MGBA). The MGBA controls the complex interactions between the brain, the enteric nervous system, the gut-associated immune system, and the enteric neuroendocrine systems, regulating key physiological functions such as the immune response, sleep, emotions and mood, food intake, and intestinal functions. Psychobiotics are considered tools with the potential to modulate the MGBA through preventive, adjunctive, or curative approaches, but their specific mechanisms of action on many aspects of health are yet to be characterized...
March 22, 2024: Microorganisms
https://read.qxmd.com/read/38674366/potential-molecular-mechanisms-of-alcohol-use-disorder-with-non-coding-rnas-and-gut-microbiota-for-the-development-of-superior-therapeutic-application
#33
REVIEW
Moeka Nakashima, Naoko Suga, Sayuri Yoshikawa, Yuka Ikeda, Satoru Matsuda
Many investigations have evaluated the expression of noncoding RNAs (ncRNAs) as well as their related molecular functions and biological machineries in individuals with alcohol dependence. Alcohol dependence may be one of the most prevailing psychological disorders globally, and its pathogenesis is intricate and inadequately comprehended. There is substantial evidence indicating significant links between multiple genetic factors and the development of alcohol dependence. In particular, the critical roles of ncRNAs have been emphasized in the pathology of mental illnesses, probably including alcohol dependence...
March 29, 2024: Genes
https://read.qxmd.com/read/38674247/a-narrative-review-of-psychobiotics-probiotics-that-influence-the-gut-brain-axis
#34
REVIEW
Laima Ķimse, Aigars Reinis, Lāsma Miķelsone-Jansone, Sandra Gintere, Angelika Krūmiņa
Mental health disorders and dementia have become a serious public health concern, with a heightened frequency of diagnoses observed in the wake of the global COVID-19 pandemic. Psychobiotics, a novel area of research at the intersection of microbiology and neuroscience, explore the potential of probiotics to influence the nervous system and mental health outcomes. This review explores the intricate mechanisms by which psychobiotics interact with the gut-brain axis, shedding light on their effects on mood, cognition, and the stress response...
April 5, 2024: Medicina
https://read.qxmd.com/read/38674014/gut-bacteria-provide-genetic-and-molecular-reporter-systems-to-identify-specific-diseases
#35
REVIEW
Leon M T Dicks
With genetic information gained from next-generation sequencing (NGS) and genome-wide association studies (GWAS), it is now possible to select for genes that encode reporter molecules that may be used to detect abnormalities such as alcohol-related liver disease (ARLD), cancer, cognitive impairment, multiple sclerosis (MS), diabesity, and ischemic stroke (IS). This, however, requires a thorough understanding of the gut-brain axis (GBA), the effect diets have on the selection of gut microbiota, conditions that influence the expression of microbial genes, and human physiology...
April 17, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38673018/neuroinflammation-and-schizophrenia-new-therapeutic-strategies-through-psychobiotics-nanotechnology-and-artificial-intelligence-ai
#36
REVIEW
Freiser Eceomo Cruz Mosquera, Maria Camila Guevara-Montoya, Valentina Serna-Ramirez, Yamil Liscano
The prevalence of schizophrenia, affecting approximately 1% of the global population, underscores the urgency for innovative therapeutic strategies. Recent insights into the role of neuroinflammation, the gut-brain axis, and the microbiota in schizophrenia pathogenesis have paved the way for the exploration of psychobiotics as a novel treatment avenue. These interventions, targeting the gut microbiome, offer a promising approach to ameliorating psychiatric symptoms. Furthermore, advancements in artificial intelligence and nanotechnology are set to revolutionize psychobiotic development and application, promising to enhance their production, precision, and effectiveness...
April 6, 2024: Journal of Personalized Medicine
https://read.qxmd.com/read/38672262/the-impact-of-gut-microbiota-changes-on-methotrexate-induced-neurotoxicity-in-developing-young-rats
#37
JOURNAL ARTICLE
Yu-Chieh Chen, Chih-Yao Hou, Mei-Hsin Hsu, Li-Tung Huang, Chih-Cheng Hsiao, Jiunn-Ming Sheen
Methotrexate (MTX) is an essential part of therapy in the treatment of acute lymphoblastic leukemia (ALL) in children, and inferior intellectual outcomes have been reported in children who are leukemia survivors. Although several studies have demonstrated that the interaction between gut microbiota changes and the brain plays a vital role in the pathogenesis of chemotherapy-induced brain injury, preexisting studies on the effect of MTX on gut microbiota changes focused on gastrointestinal toxicity only. Based on our previous studies, which revealed that MTX treatment resulted in inferior neurocognitive function in developing young rats, we built a young rat model mimicking MTX treatment in a child ALL protocol, trying to investigate the interactions between the gut and brain in response to MTX treatment...
April 19, 2024: Biomedicines
https://read.qxmd.com/read/38671931/hormetic-nutrition-and-redox-regulation-in-gut-brain-axis-disorders
#38
REVIEW
Maria Scuto, Francesco Rampulla, Giuseppe Maria Reali, Sestina Maria Spanò, Angela Trovato Salinaro, Vittorio Calabrese
The antioxidant and anti-inflammatory effects of hormetic nutrition for enhancing stress resilience and overall human health have received much attention. Recently, the gut-brain axis has attracted prominent interest for preventing and therapeutically impacting neuropathologies and gastrointestinal diseases. Polyphenols and polyphenol-combined nanoparticles in synergy with probiotics have shown to improve gut bioavailability and blood-brain barrier (BBB) permeability, thus inhibiting the oxidative stress, metabolic dysfunction and inflammation linked to gut dysbiosis and ultimately the onset and progression of central nervous system (CNS) disorders...
April 18, 2024: Antioxidants (Basel, Switzerland)
https://read.qxmd.com/read/38671923/porcine-brain-enzyme-hydrolysate-enhances-immune-function-and-antioxidant-defense-via-modulation-of-gut-microbiota-in-a-cyclophosphamide-induced-immunodeficiency-model
#39
JOURNAL ARTICLE
Yu Yue, Hye Jeong Yang, Ting Zhang, Chen Li, Min Jung Kim, Keun-Nam Kim, Sunmin Park
This study examined how consuming porcine brain enzyme hydrolysate (PBEH) affects the immune function and composition of the gut microbiota in an immunodeficient animal model. Male Wistar rats aged 6 weeks were fed casein (control), 100 mg/kg body weight (BW), red ginseng extract (positive-control), and 6, 13, and 26 mg PBEH per kg BW (PBEH-L, PBEH-M, and PBEH-H, respectively) daily for 4 weeks. At 30 min after consuming assigned compounds, they were orally administered cyclophosphamide (CTX; 5 mg/kg BW), an immunosuppressive agent, to suppress the immune system by inhibiting the proliferation of lymphocytes...
April 17, 2024: Antioxidants (Basel, Switzerland)
https://read.qxmd.com/read/38671591/the-impact-of-transcutaneous-electrical-acustimulation-tea-on-rectal-distension-induced-pain-in-patients-with-irritable-bowel-syndrome-ibs-a-study-to-determine-the-optimal-tea-delivery-modalities-and-effects-on-rectal-sensation-and-autonomic-function
#40
JOURNAL ARTICLE
Borko Nojkov, Colin Burnett, Lydia Watts, Jieyun Yin, Khawar Ali, Tingting Zhao, Shiyuan Gong, Candice Miller, Matthew Habrowski, William D Chey, Jiande D Z Chen
BACKGROUND: Treatment options for abdominal pain in IBS are inadequate. TEA was reported effective treatment of disorders of gut-brain interaction but its mechanism of action and optimal delivery method for treating pain in IBS are unknown. This study aims to determine the most effective TEA parameter and location to treat abdominal pain in patients with IBS-Constipation and delineate the effect of TEA on rectal sensation and autonomic function. METHODS: Nineteen IBS-C patients underwent TEA at acupoints ST36 (leg), PC6 (wrist), or sham-acupoint...
April 26, 2024: Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society
keyword
keyword
80052
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.